BIOLASE, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Concentrations (Tables)

Concentrations (Tables)

9 Months Ended

Sep. 30, 2014

Risks And Uncertainties [Abstract]

Summary of Net Revenue from Various Products

Revenue from the Company’s products for the three and nine months ended September 30, 2014 and 2013 are as follows:

	Three Months Ended								Nine Months Ended
	September 30,								September 30,
	2014				2013				2014				2013
Laser systems		57.9	%			65.8	%			60.2	%			67.9	%
Imaging systems		11.0	%			7.8	%			9.5	%			8.1	%
Consumables and other		12.6	%			13.2	%			13.6	%			11.9	%
Services		18.2	%			12.9	%			16.3	%			11.7	%
License fees and royalties		0.3	%			0.3	%			0.4	%			0.4	%
Total revenue		100.0	%			100.0	%			100.0	%			100.0	%

Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.

+ References + Details